Accessibility Menu
 
Evaxion A/s logo

Evaxion A/s

(NASDAQ) EVAX

Current Price$3.84
Market Cap$31.53M
Since IPO (2021)-99%
5 Year-99%
1 Year+124%
1 Month+21%

Evaxion A/s Financials at a Glance

Market Cap

$31.53M

Revenue (TTM)

$7.55M

Net Income (TTM)

$7.73M

EPS (TTM)

$-1.23

P/E Ratio

-3.07

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$3.84

Volume

78

Open

$3.72

Previous Close

$3.84

Daily Range

$3.72 - $3.84

52-Week Range

$1.20 - $12.15

EVAX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evaxion A/s

Industry

Biotechnology

Employees

46

CEO

Helena Katrina Tayton-Martin, PhD, MBA

Headquarters

Horsholm, 2970, DK

EVAX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-101%

Return on Capital

-38%

Return on Assets

-27%

Earnings Yield

-32.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$31.53M

Shares Outstanding

8.34M

Volume

78

Short Interest

0.00%

Avg. Volume

46.79K

Financials (TTM)

Gross Profit

$7.53M

Operating Income

$9.26M

EBITDA

$8.65M

Operating Cash Flow

$6.65M

Capital Expenditure

$11.03K

Free Cash Flow

$6.66M

Cash & ST Invst.

$23.23M

Total Debt

$7.50M

Evaxion A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$22.04K

-81.9%

Gross Profit

$7.53M

-6271.3%

Gross Margin

-341.61%

N/A

Market Cap

$31.53M

N/A

Market Cap/Employee

$685.35K

N/A

Employees

46

N/A

Net Income

$5.94M

-63.6%

EBITDA

$8.20M

-48.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$15.73M

+411.5%

Accounts Receivable

$1.05M

-43.4%

Inventory

$0.00

N/A

Long Term Debt

$6.95M

-27.8%

Short Term Debt

$549.99K

+16.3%

Return on Assets

-27.21%

N/A

Return on Invested Capital

-38.35%

N/A

Free Cash Flow

$6.66M

N/A

Operating Cash Flow

$6.65M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CELUCelularity Inc.
$1.33+1.53%
BTAIBioXcel Therapeutics, Inc.
$1.18-3.28%
MURAMural Oncology plc
$2.04+0.00%
GBIOGeneration Bio Co.
$5.34+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About EVAX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.